Cormorant Asset Management, LP Deciphera Pharmaceuticals, Inc. Transaction History

Cormorant Asset Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $1.11 Million - $5.36 Million	-144,439 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $1.82 Million - $2.66 Million	-55,561 Reduced 27.78%	144,439 $5.29 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $2.59 Million - $3.31 Million	-50,000 Reduced 20.0%	200,000 $11.4 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $3.02 Million - $4.01 Million	-68,914 Reduced 21.61%	250,000 $12.8 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $1.15 Million - $2.02 Million	-31,086 Reduced 8.88%	318,914 $19 Million

Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $3.36 Million - $6.94 Million	-100,000 Reduced 22.22%	350,000 $14.4 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $10.7 Million - $23.7 Million	-338,500 Reduced 42.93%	450,000 $28 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $15.7 Million - $30.6 Million	788,500 New	788,500 $26.8 Million

178

59.6M

5.3K

27.6K

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.